ACADIA Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.

About ACAD

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.

CEO

Stephen R. Davis

CEOStephen R. Davis

Employees

598

Employees598

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1993

Founded1993

Employees

598

Employees598

ACAD Key Statistics

Market cap

2.73B

Market cap2.73B

Price-Earnings ratio

-44.03

Price-Earnings ratio-44.03

Dividend yield

—

Dividend yield—

Average volume

1.43M

Average volume1.43M

High today

$16.84

High today$16.84

Low today

$16.55

Low today$16.55

Open price

$16.81

Open price$16.81

Volume

1.30M

Volume1.30M

52 Week high

$33.99

52 Week high$33.99

52 Week low

$16.55

52 Week low$16.55

ACAD News

Yahoo Finance 4h

Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024 - Yahoo Finance

Company to host conference call and webcast on Wednesday, May 8, 2024, at 4:30 p.m. Eastern Time SAN DIEGO, April 24, 2024--(BUSINESS WIRE)--Acadia Pharmaceuti...

Simply Wall St 12h

ACADIA Pharmaceuticals Inc.'s Price Is Right But Growth Is Lacking - Simply Wall St

ACADIA Pharmaceuticals Inc.'s ( ) price-to-sales (or "P/S") ratio of 3.8x might make it look like a strong buy right now compared to the Biotechs industry in th...

Analyst ratings

71%

of 21 ratings

Buy

71.4%

Hold

23.8%

Sell

4.8%